GC-MS Determination of Flunitrazepam and its Major Metabolite in Whole Blood and Plasma

Elsohly, M.A.; Feng, S.; Salamone, S.J.; Brenneisen, R. (1999). GC-MS Determination of Flunitrazepam and its Major Metabolite in Whole Blood and Plasma. Journal of analytical toxicology, 23(6), pp. 486-489. Oxford University Press 10.1093/jat/23.6.486

Preview

Text 23-6-486.pdf - Published Version Available under License Publisher holds Copyright. Download (358kB) | Preview

A gas chromatography-mass spectrometry method was developed for the analysis of flunitrazepam (FN) and its major metabolite, 7-amino-flunitrazepam (7-amino-FN), in both plasma and whole blood. The method was based on acid hydrolysis of the samples after dilution with HPLC water followed by extraction and derivatization (heptafluorobutyrate) of the resulting benzophenones. Analysis of plasma and whole blood samples from subjects administered 2-mg doses of FN showed that FN was only detected in whole blood (LOD 5 ng/mL) and not in plasma. However, 7-Amino-FN was detected in both plasma and whole blood, although the levels were much higher in plasma. 7-Amino-FN was detected for the entire period of specimen collection (12 h), but FN was only detected in whole blood for 4 h after ingestion with peak levels after 1 h.

Interest & Impact

Downloads

140 since deposited on 02 Sep 2020
34 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item